Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Gross Margin (2017 - 2020)

Historic Gross Margin for Ironwood Pharmaceuticals (IRWD) over the last 7 years, with Q4 2020 value amounting to 99.23%.

  • Ironwood Pharmaceuticals' Gross Margin rose 79500.0% to 99.23% in Q4 2020 from the same period last year, while for Dec 2020 it was 99.19%, marking a year-over-year increase of 64400.0%. This contributed to the annual value of 99.19% for FY2020, which is 47700.0% up from last year.
  • According to the latest figures from Q4 2020, Ironwood Pharmaceuticals' Gross Margin is 99.23%, which was up 79500.0% from 100.0% recorded in Q3 2020.
  • In the past 5 years, Ironwood Pharmaceuticals' Gross Margin registered a high of 100.0% during Q2 2020, and its lowest value of 83.58% during Q4 2018.
  • Its 4-year average for Gross Margin is 94.85%, with a median of 95.61% in 2018.
  • In the last 5 years, Ironwood Pharmaceuticals' Gross Margin plummeted by -68900bps in 2018 and then surged by 110700bps in 2020.
  • Quarter analysis of 4 years shows Ironwood Pharmaceuticals' Gross Margin stood at 90.46% in 2017, then fell by -8bps to 83.58% in 2018, then grew by 9bps to 91.28% in 2019, then increased by 9bps to 99.23% in 2020.
  • Its last three reported values are 99.23% in Q4 2020, 100.0% for Q3 2020, and 100.0% during Q2 2020.